Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Zymeworks Inc (ZYME)
NASDAQ:ZYME
Zymeworks (ZYME) Stock Price & Analysis
387 Followers
ZYME Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.11 - $10.80
Previous Close$8.73
Volume88.79K
Average Volume (3M)527.82K
Market Cap
$552.34M
Enterprise Value$101.83M
Total Cash (Recent Filing)$492.23M
Total Debt (Recent Filing)$28.11M
Price to Earnings (P/E)3.4
Beta0.71
Next Earnings
Aug 02, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.58
Shares Outstanding57,892,785
10 Day Avg. Volume409,042
30 Day Avg. Volume527,820
Standard Deviation0.17
R-Squared0.09
Alpha-0.00956
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)1.23
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.25
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda0.71
Forecast
1Y Price Target
$12.88Price Target Upside51.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Zymeworks News
Stock Analysis & Ideas3 Best Stocks to Buy Now, 5/19/2023, According to Top Analysts
Pre-EarningsIs ZYME a Buy, Before Earnings?
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ZYME FAQ
What was Zymeworks Inc’s price range in the past 12 months?
Zymeworks Inc lowest stock price was $4.11 and its highest was $10.80 in the past 12 months.
What is Zymeworks Inc’s market cap?
Currently, no data Available
When is Zymeworks Inc’s upcoming earnings report date?
Zymeworks Inc’s upcoming earnings report date is Aug 02, 2023 which is in 54 days.
How were Zymeworks Inc’s earnings last quarter?
Zymeworks Inc released its earnings results on May 08, 2023. The company reported -$0.37 earnings per share for the quarter, beating the consensus estimate of -$0.536 by $0.166.
Is Zymeworks Inc overvalued?
According to Wall Street analysts Zymeworks Inc’s price is currently Undervalued.
Does Zymeworks Inc pay dividends?
Zymeworks Inc does not currently pay dividends.
What is Zymeworks Inc’s EPS estimate?
Zymeworks Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zymeworks Inc have?
Zymeworks Inc has 64,171,280 shares outstanding.
What happened to Zymeworks Inc’s price movement after its last earnings report?
Zymeworks Inc reported an EPS of -$0.37 in its last earnings report, beating expectations of -$0.536. Following the earnings report the stock price went up 12.785%.
Which hedge fund is a major shareholder of Zymeworks Inc?
Among the largest hedge funds holding Zymeworks Inc’s share is Perceptive Advisors LLC. It holds Zymeworks Inc’s shares valued at 31M.
---
Zymeworks Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.88 (51.17% Upside)
$12.88 (51.17% Upside)
Blogger Sentiment
Bullish
ZYME Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 2.9M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $3.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.1%
Last 30 Days ▲ 12.4%
Last 30 Days ▲ 12.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
25.61%
12-Months-Change
Fundamentals
Return on Equity
45.67%
Trailing 12-Months
Asset Growth
39.72%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Zymeworks Inc
Zymeworks, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani, and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.
---
Top 5 ETFs holding ZYME
Picton Mahoney Fortified Long Short Alternative Fund Trust Units
$377.06K
Fidelity MSCI Health Care Index ETF
$146.03K
Dimensional U.S. Equity ETF
$82.31K
Picton Mahoney Fortified Active Extension Alternative Fund ETF
$74.19K
Up to five ETFs with an Outperform Smart Score that hold ZYME. The ETFs are listed according to market value of ZYME within the ETF
---
---